ADMA Biologics, Inc.ADMANASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+363.8%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
+363.8%/yr
Quarterly compound
Percentile
P100
Near historical high
vs 3Y Ago
99.7x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 3314.42% |
| Q3 2025 | -105.74% |
| Q2 2025 | 176.78% |
| Q1 2025 | -151.36% |
| Q4 2024 | 97.98% |
| Q3 2024 | -44.99% |
| Q2 2024 | 1054.66% |
| Q1 2024 | -127.84% |
| Q4 2023 | 46.05% |
| Q3 2023 | 261.99% |
| Q2 2023 | 58.41% |
| Q1 2023 | -49.79% |
| Q4 2022 | 33.23% |
| Q3 2022 | 0.63% |
| Q2 2022 | 41.88% |
| Q1 2022 | 22.31% |
| Q4 2021 | -129.25% |
| Q3 2021 | 55.90% |
| Q2 2021 | -2.62% |
| Q1 2021 | 0.05% |
| Q4 2020 | -33.96% |
| Q3 2020 | -5.05% |
| Q2 2020 | 4.75% |
| Q1 2020 | -25.77% |
| Q4 2019 | 17.01% |
| Q3 2019 | -36.48% |
| Q2 2019 | -30.29% |
| Q1 2019 | 26.59% |
| Q4 2018 | -53.54% |
| Q3 2018 | 17.08% |
| Q2 2018 | 9.29% |
| Q1 2018 | -10.51% |
| Q4 2017 | -49.07% |
| Q3 2017 | -16.25% |
| Q2 2017 | -64.17% |
| Q1 2017 | -49.07% |
| Q4 2016 | 22.71% |
| Q3 2016 | 3.22% |
| Q2 2016 | 6.57% |
| Q1 2016 | -27.29% |